A TECHNO-ECONOMIC NEWS MAGAZINE FOR MEDICAL PLASTICS AND PHARMACEUTICAL INDUSTRY
Page 1 of 4

Quality

Sterility Testing For Medical Devices

- Dr. Nishodh Saxena, Scientist, B.V. Patel Pharamceutical Education Research Centre (PERD), Ahmedabad, Gujarat, India.

Test for sterility :

Dr. Nishodh Saxena, Research Scientist, Dept. of Microbiology, Pharmaceutical Education Research & Development (PERD) Centre

Intended for detecting the presence of viable forms  of    microorganisms    in     on       Pharmacopoeial preparations  and articles. The following procedures are    applicable    for    determining    whether   a Pharmacopoeial article  purporting   to   be   sterile complies  with  the   requirements  set  forth  in  the individual monograph with respect  to  the  test  for sterility.

Principle:  

The tests are based upon the principle that if microorganisms are placed in a medium which provides nutritive material and water and kept at a favourable temperature, the organisms will grow and their presence can be indicated by a turbidity in the originally clear medium.

Design and Precautions:

Designed to avoid accidental contamination of the product during the test. Precautions taken for this purpose should not adversely affect any microorganisms which should be revealed in the test.

The working conditions in which the tests are performed should be monitored regularly by carrying out control tests.

Batch:

A homogeneous collection of sealed containers prepared in such a manner that the risk of contamination is same for each of the unit in it.

Limitations:

  • Within the strictest definition of sterility, a specimen would be deemed sterile only when there is complete absence of viable microorganisms from it. However this absolute definition can not currently be applied to an entire lot of finished compendial articles because of limitations in testing.  

  • Absolute sterility can not be practically demonstrated without complete destruction of every finished article. The sterility of a lot purported to be sterile is therefore defined in probabilistic terms, where the likelihood of a contaminated unit or article is acceptably remote.

  • Such a state of sterility assurance can be established only through the use of adequate sterilization cycles and subsequent aseptic processing, if any, under appropriate current good manufacturing practice, and not by reliance solely on sterility testing.

  • The probability of detecting viable microorganisms in the tests for sterility increases with the number present in a given amount of the preparation being examined and varies according to the species of microorganism present.  

  • Very low levels of contamination can not be detected on the basis of random sampling of a batch.  

  • If contamination is not uniform throughout the batch, random sampling can not detect contamination with certainty.  

Guidelines for the selection of minimum number of items recommended to be tested in a batch.

Number of item in the batch

Minimum number of items recommended to be tested in IP

Minimum number of items recommended to be tested in usp

Injectable preparations

1.     Not more than 100 containers/articles

2.     More than 100 but not more than 500 container

3.     More than 500 containers

4.      For large - volume parenterals

 

10% or 4 whichever is greater

 

10 containers

 

2% or 20 containers whichever is less

--

 

10% or 4 whichever is greater

 

10 containers

 

2% or 20 containers whichever is less

2% or 10 containers whichever is less

Ophthalmic and other non Injectable preparations

1.     Not more than 200 containers

2.     More than 200 containers

 

 

5% or 2 containers whichever is greater

10 containers

 

 

5% or 2 containers whichever is greater

10 containers

Surgical dressings/Devices

1.     Not more than 100 packages

2.     More than 100 but not more than 500 packages

3.     More than 500 packages

 

10% or 4 packages whichever is greater

 

10 packages

2% or 20 packages whichever is less

 

10% or 4 packages whichever is greater

 

10 packages

2% or 20 packages whichever is less

Bulk solids

1.      Less than 4 containers

2.     4 containers but not more than 50 containers

 

3.     More than 50 containers

 

Each container

 

20% or 4 containers whichever is greater

2% or 10 containers whichever is greater

 

Each container

 

20% or 4 containers whichever is greater

2% or 10 containers whichever is greater

Antibiotic Solids

Pharmacy bulk packages

 (<5 g)

Pharmacy bulk packages

(³5 g)

bulks and blends

 

--

 

--

 

--

 

20 containers

 

6 containers

 

as per solid bulk products

Culture Media:

Media for the tests may be prepared as given below or dehydrated mixtures yielding similar formulations may be used provided that when reconstituted as directed by the manufacturer, they have growth promoting properties equal to or superior to those from the formulae given below.

Fluid thioglycollate medium  

Ingredients  
Quantity
L-Cystine  00.50 g  
Sodium Chloride 02.50 g  
Dextrose(C6H12O6.H2O)  05.50 g  
Granular agar (moisture less than 15%w/w)  00.75 g  
Yeast extract (water soluble) 05.00 g  
Pancreatic digest of casein  15.00 g  
Sodium thioglycollate or 00.50 g  
Thioglycollic acid 00.30 g  
Resazurin  (0.10% fresh solution)  01.00 ml
Distilled water to 1000  ml  
pH (after sterilization) 7.1±0.2

Distribute into suitable vessels which provide a ratio of surface to depth of medium such that not more than the upper half of the medium has undergone a colour change, indicative of oxygen uptake at the end of the incubating period.

  • Sterilize in an autoclave at 121°C for 20 minutes. Cool promptly to 25°C and store at 20-30°C, avoiding excess of light. Medium can be used within 3 weeks only.

  • Use fluid thioglycollate medium by incubating it at 30-35°C under aerobic conditions.

Alternative thioglycollate medium:

For use with turbid and viscid products and for devices having tubes with small lumina.  

Ingredients   
Quantity
L-Cystine 00.50 g  
Sodium Chloride 02.50 g  
Dextrose(C6H12O6.H2O) 05.50 g
Yeast extract (water soluble)  05.00 g  
Pancreatic digest of casein 15.00 g  
Sodium thioglycollate or 00.50 g  
Thioglycollic acid 00.30 g
Distilled water to   1000  ml  
pH (after sterilization)   7.1±0.2  
Use Alternative fluid thioglycollate medium by incubating it at 30-35°C under anaerobic conditions.
| Page 1 | Page 2 | Page 3 | Page 4 | Back | Back To Top